Insulet | PODD - Stock


Insulet reported $484.8M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Align Technology USD 212.24M 2.7M Jun/2026
AtriCure USD 83.92M 2.78M Jun/2026
Baxter International USD 2.26B 57M Jun/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Boston Scientific USD 3.24B 118M Jun/2026
Cardinal Health USD 17.3B 710M Jun/2026
Cooper Companies USD 896.4M 20M Mar/2026
Dexcom USD 726.4M 32.8M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Globus Medical USD 810.9M 38.3M Jun/2026
ICU Medical USD 607.42M 1.83M Jun/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 484.8M 22.3M Jun/2026
Integra LifeSciences USD 492M 3.03M Jun/2026
J&J USD 15.14B 561M Jun/2026
Medtronic USD 6.22B 264M Jun/2026
Merit Medical Systems USD 374.11M 21.73M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Solventum Corp USD 1.04B 49M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Tandem Diabetes Care USD 135.11M 8.71M Jun/2026
Teleflex USD 351.91M 28.95M Jun/2026
West Pharmaceutical Services USD 447.4M 5.2M Jun/2026
Zimmer Biomet Holdings USD 2.27B 23.5M Jun/2026